| Abstrakt: |
Keywords: Mie; Japan; Asia; Antiarrhythmic Agents; Cardiology; Cardiovascular Agents; Cardiovascular Diseases and Conditions; Cyborgs; Digoxin Therapy; Drugs and Therapies; Emerging Technologies; Group V Antiarrhythmics; Health Personnel; Health and Medicine; Heart Disease; Heart Disorders and Diseases; Heart Failure; Inotropic Agents; Machine Learning; Medical Staff; Pharmaceuticals; Risk and Prevention EN Mie Japan Asia Antiarrhythmic Agents Cardiology Cardiovascular Agents Cardiovascular Diseases and Conditions Cyborgs Digoxin Therapy Drugs and Therapies Emerging Technologies Group V Antiarrhythmics Health Personnel Health and Medicine Heart Disease Heart Disorders and Diseases Heart Failure Inotropic Agents Machine Learning Medical Staff Pharmaceuticals Risk and Prevention 298 298 1 06/19/23 20230623 NES 230623 2023 JUN 19 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Data detailed on Heart Disorders and Diseases - Heart Failure have been presented. According to news reporting originating from Mie, Japan, by NewsRx correspondents, research stated, "Digoxin toxicity (plasma digoxin concentration >= 0.9 ng/mL) is associated with worsening heart failure (HF). [Extracted from the article] |
